Cel Sci Corporation (CVM)

[Phoenix2020]

Upcoming FDA Filing

The following can be found in an article on 'New Research Released on CEL-SCI Corporation' (https://www.crystalra.com/blog/cel-sci-1):

"Upcoming FDA Filing
CEL-SCI has met with the FDA and received their questions and comments. The Company expects to submit a major follow-up package to the FDA very soon, addressing any of its questions or comments. CEL-SCI also expects to file the Clinical Study Report, which is typically filed with a Biologics License Application (BLA). CEL-SCI’s treatment is novel and its data is extensive and solid. The Company has been able to identify with high accuracy the patients who are most likely to have great overall survival benefit from Multikine®, which includes over 210,000 patients per year globally. CEL-SCI also continues to validate its manufacturing facility to ensure it will follow the standards for a BLA approval."